Clinical trials
Phase 2 Hematologic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Janssen Research & Development, LLC | 2 |
| Kiadis Pharma | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Cogent Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 13 |
| Leukemia, Myeloid, Acute | 4 |
| Myelodysplastic Syndromes | 3 |
| Graft vs Host Disease | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Hematologic Diseases | 1 |
| Hypersensitivity | 1 |
| Immune Complex Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.